DCM Shriram Fine

Why is DCM Shriram Fine Chemicals Ltd falling/rising?

As of 10-Jun, DCM Shriram Fine Chemicals Ltd's stock price is declining at 23.73, down 0.96%, with an 18.17% drop over the past month. The company reported significant financial losses, including a negative profit after tax and low net sales, contributing to a bearish trend and reduced institutional investor confidence.

As of 10-Jun, DCM Shriram Fine Chemicals Ltd is experiencing a decline in its stock price, currently at 23.73, which reflects a change of -0.23 or -0.96%. The stock has underperformed significantly over the past month, with a decrease of 18.17%, compared to a smaller decline of 4.33% in the benchmark Sensex. The company's financial performance has been troubling, as it reported an operating loss, with a negative profit after tax of Rs -4.08 crore, which is a drastic fall of 866.2% compared to the previous four-quarter average. Additionally, net sales were reported at their lowest at Rs 93.08 crore, and the company recorded a negative EBIT of Rs -4.84 crore.<BR><BR>Despite a slight trend reversal today, where the stock gained after three consecutive days of decline, it is still trading below all key moving averages, indicating a bearish trend. Furthermore, there has been a decrease in participation from institutional investors, who have reduced their stake by 0.82% over the previous quarter, suggesting a lack of confidence in the company's long-term fundamentals. Overall, the combination of poor financial results, negative operating profits, and declining institutional interest contributes to the stock's downward movement.

What does DCM Shriram Fine do?

DCM Shriram Fine Chemicals Ltd is a micro-cap company in the commodity chemicals industry, incorporated in 2021 as a public limited company. As of March 2026, it reported net sales of 93 Cr and a net loss of 4 Cr, with a market cap of INR 210 Cr.

Overview:<BR>DCM Shriram Fine Chemicals Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated on September 29, 2021, as a Public Limited Company, with a Certificate of Incorporation issued on September 30, 2021. Prior to this, it was a wholly owned subsidiary of DCM Shriram Industries Limited. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 93 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -4 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 210 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 42 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.21 <BR>Return on Equity: -2.14% <BR>Price to Book: 1.04 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Which are the latest news on DCM Shriram Fine?

How big is DCM Shriram Fine?

As of 10th June, DCM Shriram Fine Chemicals Ltd has a market capitalization of 210.00 Cr and reported net sales of 400.02 Cr, but incurred a net loss of 3.43 Cr, with no available balance sheet data for the latest annual period.

As of 10th June, DCM Shriram Fine Chemicals Ltd has a market capitalization of 210.00 Cr and is classified as a Micro Cap.<BR><BR>In the latest 4 quarters, the company reported net sales of 400.02 Cr. However, it experienced a loss of 3.43 Cr in net profit during the same period.<BR><BR>There is no valid balance sheet data available for the latest annual period, which means values for Shareholder's Funds and Total Assets cannot be provided.

Who are the peers of the DCM Shriram Fine?

Peers of DCM Shriram Fine include Alufluoride, National Perox., Hind.Organ.Chem., and others, with varying management and growth risks. Genus Prime leads in 1-year returns at 14.63%, while ZR2 Bioenergy has the lowest at -68.86%.

Peers: The peers of DCM Shriram Fine are Alufluoride, National Perox., Hind.Organ.Chem., Genus Prime, ZR2 Bioenergy, Kesar Petroprod., IVP, Kanchi Karpooram, ARCL Organics, AG Ventures.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride and ARCL Organics, while Average management risk is found at National Perox., Kesar Petroprod., IVP, and Kanchi Karpooram, and the rest have Below Average management risk. Good growth is seen at Alufluoride, Genus Prime, and Kesar Petroprod., while Average growth is found at IVP, and the rest have Below Average growth. For capital structure, Excellent is noted at Kanchi Karpooram, Good at Alufluoride, National Perox., ARCL Organics, and Average at Kesar Petroprod., IVP, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Genus Prime at 14.63%, while ZR2 Bioenergy has the lowest at -68.86%. DCM Shriram Fine's 1-year return is not available for comparison. Additionally, several peers, including ZR2 Bioenergy, Kesar Petroprod., ARCL Organics, and AG Ventures, have negative six-month returns.

Should I buy, sell or hold DCM Shriram Fine Chemicals Ltd?

Are DCM Shriram Fine Chemicals Ltd latest results good or bad?

DCM Shriram Fine Chemicals Ltd's latest results are concerning, showing a net loss of ₹3.83 crore in Q4 FY26, marking a 260.25% decline year-on-year. The company has faced three consecutive quarters of losses, negative operating margins, and a return on equity of -2.14%, indicating significant operational challenges and a negative outlook.

The latest results for DCM Shriram Fine Chemicals Ltd are concerning and indicate a significant decline in financial performance. In Q4 FY26, the company reported a net loss of ₹3.83 crore, which is a drastic drop of 260.25% year-on-year. This marks the third consecutive quarter of losses, with the losses widening compared to the previous quarter.<BR><BR>Operating margins have also deteriorated sharply, turning negative at -2.71%, down from a positive 6.78% in the same quarter last year. This reflects severe operational challenges, as the company is unable to cover its basic operating expenses from its core business activities. Additionally, net sales fell slightly by 0.29% year-on-year to ₹93.08 crore, but this decline masks deeper issues within the company's operations.<BR><BR>The return on equity has collapsed to -2.14%, indicating that the company is not generating returns for its shareholders. Overall, the financial performance suggests that DCM Shriram Fine Chemicals is facing an operational crisis, raising serious concerns about its viability moving forward. Given these results, the outlook appears quite negative.

When is the next results date for DCM Shriram Fine Chemicals Ltd?

The next results date for DCM Shriram Fine Chemicals Ltd is 19 May 2026.

The next results date for DCM Shriram Fine Chemicals Ltd is scheduled for 19 May 2026.